These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 10888412)

  • 1. Strategies offering protection from the toxic effects of anticancer treatments with a focus on chemoprotective agents.
    Awada A; Piccart M
    Curr Opin Oncol; 2000 Jul; 12(4):289-96. PubMed ID: 10888412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antioxidants and chemotherapy.
    Galland L
    Altern Ther Health Med; 2007; 13(5):13. PubMed ID: 17900036
    [No Abstract]   [Full Text] [Related]  

  • 3. Chemoradiotherapy for head and neck cancer: 'local' side effects are actually systemic.
    J Support Oncol; 2006 Feb; 4(2):88. PubMed ID: 16499131
    [No Abstract]   [Full Text] [Related]  

  • 4. American Society of Clinical Oncology clinical practice guidelines for the use of chemotherapy and radiotherapy protectants.
    Hensley ML; Schuchter LM; Lindley C; Meropol NJ; Cohen GI; Broder G; Gradishar WJ; Green DM; Langdon RJ; Mitchell RB; Negrin R; Szatrowski TP; Thigpen JT; Von Hoff D; Wasserman TH; Winer EP; Pfister DG
    J Clin Oncol; 1999 Oct; 17(10):3333-55. PubMed ID: 10506637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antioxidants and other nutrients do not interfere with chemotherapy or radiation therapy and can increase kill and increase survival, part 1.
    Simone CB; Simone NL; Simone V; Simone CB
    Altern Ther Health Med; 2007; 13(1):22-8. PubMed ID: 17283738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antioxidants and other nutrients do not interfere with chemotherapy or radiation therapy and can increase kill and increase survival, Part 2.
    Simone CB; Simone NL; Simone V; Simone CB
    Altern Ther Health Med; 2007; 13(2):40-7. PubMed ID: 17405678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Side effects of adjuvant treatment of breast cancer.
    Shapiro CL; Recht A
    N Engl J Med; 2001 Jun; 344(26):1997-2008. PubMed ID: 11430330
    [No Abstract]   [Full Text] [Related]  

  • 8. Morbidities of adjuvant chemotherapy and radiotherapy for resectable rectal cancer: an overview.
    Ooi BS; Tjandra JJ; Green MD
    Dis Colon Rectum; 1999 Mar; 42(3):403-18. PubMed ID: 10223765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytoprotective Agents to Avoid Chemotherapy Induced Sideeffects on Normal Cells: A Review.
    Rohilla S; Dureja H; Chawla V
    Curr Cancer Drug Targets; 2019; 19(10):765-781. PubMed ID: 30914026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Long-term consequences of anticancer therapy in children].
    Kuleva SA; Kolygin BA
    Vopr Onkol; 2012; 58(4):454-63. PubMed ID: 23607198
    [No Abstract]   [Full Text] [Related]  

  • 11. The current status of toxicity protectants in cancer therapy.
    Schuchter LM; Luginbuhl WE; Meropol NJ
    Semin Oncol; 1992 Dec; 19(6):742-51. PubMed ID: 1334280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cardiovascular complications of oncological therapy].
    Grabowska B; Stepińska J
    Kardiol Pol; 2004 Sep; 61(9):296-9. PubMed ID: 15531946
    [No Abstract]   [Full Text] [Related]  

  • 13. Oncogastroenterology.
    Grover S; Lim RM; Blumberg RS; Syngal S
    J Clin Oncol; 2016 Apr; 34(10):1154-5. PubMed ID: 26834060
    [No Abstract]   [Full Text] [Related]  

  • 14. How safe is adjuvant chemotherapy and radiotherapy for rectal cancer?
    Chao MW; Tjandra JJ; Gibbs P; McLaughlin S
    Asian J Surg; 2004 Apr; 27(2):147-61. PubMed ID: 15140670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current role of protective agents in cancer treatment.
    Schuchter LM
    Oncology (Williston Park); 1997 Apr; 11(4):505-12, 515-6; discussion 517-8. PubMed ID: 9130273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytoprotection: concepts and challenges.
    Muggia FM
    Support Care Cancer; 1994 Nov; 2(6):377-9. PubMed ID: 7858930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection of normal tissue from the cytotoxic effects of chemotherapy and radiation by amifostine: clinical experiences.
    Capizzi RL; Oster W
    Eur J Cancer; 1995; 31A Suppl 1():S8-13. PubMed ID: 7577096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Designing dose-escalation trials with late-onset toxicities using the time-to-event continual reassessment method.
    Normolle D; Lawrence T
    J Clin Oncol; 2006 Sep; 24(27):4426-33. PubMed ID: 16983110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cardioprotective treatment during adjuvant cancer therapy].
    Gulati G; Heck SL; Ree AH; Gravdehaug B; Røsjø H; Steine K; Bratland Å; Hoffmann P; Geisler J; Omland T
    Tidsskr Nor Laegeforen; 2013 Sep; 133(17):1832-6. PubMed ID: 24042297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Amifostine as a supporting treatment during cancer therapy].
    Jantunen E; Puistola U
    Duodecim; 1999; 115(11):1223-7. PubMed ID: 11877841
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.